Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

INMDBullishM&Anews

High materiality8/10

InMode Faces Unsolicited $16.20/Share Buyout Proposal With Independent Review

Jun 24, 2026, 8:47 AM EDT2 sourcesAI-analyzed

Why it may matterVerify against the original reporting

A $16.20 cash offer establishes a near-term price floor and could spark a formal sale process; potential for higher bids or competing offers if the special committee engages, supporting upside volatility in the near term.

AI summary

What happened, with direct paths to the underlying reporting

INMD disclosed an unsolicited cash offer of $16.20 per share from MN Business Strategy. The board formed an independent special committee to evaluate the proposal, signaling a potential sale process with fiduciary review. There is no guarantee the deal will close or what terms may emerge, but the development could support near-term price action.

INMD board received unsolicited $16.20 cash offer. A special independent committee will evaluate.
Bidder MN Business Strategy includes Mizrahy; committee will assess conflicts. No deal assurance.
InMode is a leading medical tech company. RF devices span plastic surgery, dermatology.
Forward-looking statements warn of timing and deal outcome. No updates unless required by law.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

InMode Faces Unsolicited $16.20/Share Buyout Proposal With Independent Review

InMode Discontinues Transaction Process Despite Multiple Proposals

Steel Partners Targets InMode, Citing Stock Underperformance